FRIDAY, Sept. 17, 2021 (HealthDay News) — Treating sickle cell anemia with the drug hydroxyurea may also reverse related heart abnormalities, a new study suggests. Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax heart muscles,Continue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — When the COVID-19 public health emergency ends, a new crisis in insurance coverage in the United States may begin. Fifteen million Americans who enrolled in Medicaid during the pandemic could lose their coverage when the emergency declaration ends, according to an analysis byContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The “white cane” that many blind people rely on for navigating the world hasn’t been upgraded in a century, but researchers are reporting progress on a “robo-cane” they hope will modernize the assistive device. The prototype cane is equipped with a color 3DContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading